
Solving Patient Matching in Rare Disease Trials
Apr 29, 2026 - 00:33:36
Radio and PodcastLive Radio & Podcasts
After3 years in the making, the Joint Clinical Assessment for the EU is in effect. From 12th January 2025 new cancer medicines and advanced therapy medicinal products (ATMPs) will require a JCA across all 27 member state...
The JCA is live is an episode from Rare Disease, Cell & Gene Therapy Monthly RoundUp by Partners4Access. After3 years in the making, the Joint Clinical Assessment for the EU is in effect. From 12th January 2025 new cancer medicines and adva...
This episode belongs to Rare Disease, Cell & Gene Therapy Monthly RoundUp.
Use the player on this page to stream the episode online.
Published Jan 13, 2025, 00:25:24 long, audio available.